Atorvastatin recall may affect hundreds of thousands of patients – and reflects FDA’s troubles inspecting medicines manufactured overseas

This recall affects America’s most prescribed drug. It’s the latest in a series of concerning manufacturing issues that have come to light over the past few years.

© La Conversation - jeudi 30 octobre 2025